<DOC>
	<DOCNO>NCT00841958</DOCNO>
	<brief_summary>The primary objective study test endocardial stem cell implantation patient CAD , low ejection fraction sign HF without possibility CABG PCI despite previous revascularization improve long-term survival compare MED alone</brief_summary>
	<brief_title>Endocardial Stem Cells Approach Efficacy</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Men woman childbearing potential Age 2175 year . Patients CAD , NYHA CCS angina IIIIV functional class LVEF le 35 % measure echocardiography SPECT within three month study entry Unsuitable initial repeat conventional revascularization ( CABG PCI ) Failure provide inform consent . Plan PCI CABG . Noncardiac illness life expectancy le 3 year . Conditions/circumstances likely lead poor treatment adherence ( e.g. , history poor compliance , alcohol drug dependency , psychiatric illness , fix abode ) . Previous heart , kidney , liver , lung transplantation . Current participation another clinical trial patient take investigational drug receive investigational medical device . Recent acute myocardial infarction ( AMI ) within 90 day study entry Successful coronary revascularization ( Ð¡ABG PCI ) within 12 month study enrollment History moderate severe aortic stenosis prosthetic aortic valve Permanent atrial fibrillation Thrombosis LV , base echocardiography data</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>